FREQ
Income statement / Annual
Last year (2022), Frequency Therapeutics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2022, Frequency Therapeutics, Inc.'s net income was -$81.58 M.
See Frequency Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00
|
$14.07 M
|
$36.98 M
|
$28.95 M
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$14.07 M |
$36.98 M |
$28.95 M |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
1 |
1 |
1 |
0 |
0 |
| Research and Development
Expenses |
$49.42 M
|
$60.92 M
|
$37.42 M
|
$18.78 M
|
$11.88 M
|
$11.97 M
|
| General & Administrative
Expenses |
$33.58 M
|
$37.18 M
|
$27.12 M
|
$30.84 M
|
$7.06 M
|
$4.34 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$33.58 M
|
$37.18 M
|
$27.12 M
|
$30.84 M
|
$7.06 M
|
$4.34 M
|
| Other Expenses |
$1.06 M |
-$266,000.00 |
$0.00 |
$16.00 M |
$0.00 |
$0.00 |
| Operating Expenses |
$83.00 M |
$98.10 M |
$64.53 M |
$49.62 M |
$18.94 M |
$16.31 M |
| Cost And Expenses |
$83.00 M |
$98.10 M |
$64.53 M |
$49.62 M |
$18.94 M |
$16.31 M |
| Interest Income |
$1.33 M |
$397,000.00 |
$994,000.00 |
$1.78 M |
$0.00 |
-$174,000.00 |
| Interest Expense |
$961,000.00 |
$764,000.00 |
$0.00 |
$1.78 M |
$106,000.00 |
$174,000.00 |
| Depreciation &
Amortization |
$2.38 M
|
$2.91 M
|
-$80,000.00
|
-$145,000.00
|
$654,000.00
|
$531,000.00
|
| EBITDA |
-$80.62 M
|
-$81.13 M
|
-$27.55 M
|
-$20.68 M
|
-$18.29 M
|
-$12.02 M
|
| EBITDA Ratio |
0 |
-5.77 |
-0.75 |
-0.72 |
0 |
0 |
| Operating Income Ratio
|
0
|
-5.97
|
-0.74
|
-0.71
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.42 M
|
-$640,000.00
|
$1.07 M
|
$1.93 M
|
-$224,000.00
|
-$3.93 M
|
| Income Before Tax |
-$81.58 M |
-$84.67 M |
-$26.48 M |
-$18.75 M |
-$19.17 M |
-$20.24 M |
| Income Before Tax Ratio
|
0
|
-6.02
|
-0.72
|
-0.65
|
0
|
0
|
| Income Tax Expense |
-$2,000.00 |
$15,000.00 |
$35,000.00 |
-$2.74 M |
-$118,000.00 |
$3.93 M |
| Net Income |
-$81.58 M |
-$84.69 M |
-$26.51 M |
-$16.00 M |
-$19.17 M |
-$20.24 M |
| Net Income Ratio |
0 |
-6.02 |
-0.72 |
-0.55 |
0 |
0 |
| EPS |
-2.33 |
-2.47 |
-0.82 |
-1.85 |
-1.59 |
-1.68 |
| EPS Diluted |
-2.33 |
-2.47 |
-0.82 |
-1.85 |
-1.59 |
-1.68 |
| Weighted Average Shares
Out |
$35.08 M
|
$34.35 M
|
$32.25 M
|
$8.65 M
|
$12.06 M
|
$12.06 M
|
| Weighted Average Shares
Out Diluted |
$35.08 M
|
$34.35 M
|
$32.25 M
|
$8.65 M
|
$12.06 M
|
$12.06 M
|
| Link |
|
|
|
|
|
|
